S. Nassir Ghaemi MD MPH
Professor of Psychiatry, Tufts University
Lecturer on Psychiatry, Harvard Medical School
Distinguished Life Fellow, American Psychiatric Association
Diplomate, American Board of Psychiatry and Neurology
Overseas Fellow, Royal Society of Medicine
A featured psychiatric expert on CNN, MSNBC, Fox, and other media
Bestselling author of A First-Rate Madness and other books
Voted by his peers among the Best of Boston annually since 2016
Expert Psychiatric Diagnosis and Treatment
A scientifically sound, independent minded approach to psychiatry
Expert psychiatric diagnosis will be provided, assessing mood conditions, anxiety states, psychotic illnesses, cognitive issues (often diagnosed as ADD), and others
Expert psychopharmacology treatments will be provided, and need for psychotherapies will be identified.
An extensive written consultation with diagnostic reassessment and detailed treatment plan will be provided, along with ongoing follow-up consultation
S. Nassir Ghaemi MD MPH
I am Director of the Psychopharmacology Consultation Clinic at Tufts Medical Center and Professor of Psychiatry at Tufts University School of Medicine and Lecturer on Psychiatry at Harvard Medical School. My clinical work and research have focused on depression and manic-depressive illness. I have published over 300 scientific articles and have written or edited about a dozen books, including a major textbook on psychopharmacology, a book on research methods in psychiatry, and a book on leadership. The details regarding my academic publications can be reached at https://scholar.google.com/citations?user=L9XTPtgAAAAJ&hl=en.
I have been a featured psychiatric expert on CNN, MSNBC, Fox, the New York Times, the Boston Globe, and other major media. My book, A First Rate Madness, was a national bestseller and was excerpted in the Wall Street Journal, and reviewed in the New York Times, the Washington Post, the Boston Globe, and other national newspapers.
Throughout my career, I have served on a number of editorial boards of psychiatric journals. For more than five years, I have been Associate Editor of Acta Psychiatrica Scandinavica. I am a Distinguished Life Fellow of the American Psychiatric Association, the current president-elect of the Massachusetts Psychiatric Society, and am board certified in Psychiatry and Neurology.
Stress & Anxiety
Bipolar illness or mania
Having problems with antidepressants
Having problems with amphetamines
Psychiatric care sometimes is criticized for being too biological and too drug-focused. Sometimes it is criticized for being too psychological and too psychotherapy-focused. Many people can’t get psychiatric care; many who get it don’t improve.
My perspective, which I call the biohumanistic approach, published in 2023 in this scientific article, takes the view that a biological approach and drug treatment is not inherently wrong; neither is a psychological approach and psychotherapy treatment. The key is to identify who needs which approach, based on whether a psychiatric disease is present or not.
The biohumanistic approach given to those patients who do not benefit from standard practice is based on solid scientific research, on the best studies of diagnostic concepts, on randomized clinical trials of medication efficacy wherever possible, and on the best treatment data available when randomized studies are not present. This approach is scientific and humanistic, not just one or the other.
Ask a question or book an appointment below. For emergencies call 911 or visit your nearest hospital